154 related articles for article (PubMed ID: 21113699)
1. Inhibition of NF-κB signaling as a strategy in disease therapy.
Gilmore TD; Garbati MR
Curr Top Microbiol Immunol; 2011; 349():245-63. PubMed ID: 21113699
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of NF-kappaB signaling: 785 and counting.
Gilmore TD; Herscovitch M
Oncogene; 2006 Oct; 25(51):6887-99. PubMed ID: 17072334
[TBL] [Abstract][Full Text] [Related]
3. Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway.
Epinat JC; Gilmore TD
Oncogene; 1999 Nov; 18(49):6896-909. PubMed ID: 10602465
[TBL] [Abstract][Full Text] [Related]
4. Targeting IKK and NF-κB for Therapy.
Durand JK; Baldwin AS
Adv Protein Chem Struct Biol; 2017; 107():77-115. PubMed ID: 28215229
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.
Nagel D; Vincendeau M; Eitelhuber AC; Krappmann D
Oncogene; 2014 Dec; 33(50):5655-65. PubMed ID: 24469030
[TBL] [Abstract][Full Text] [Related]
6. Novel non-peptide small molecules preventing IKKβ/NEMO association inhibit NF-κB activation in LPS-stimulated J774 macrophages.
De Falco F; Di Giovanni C; Cerchia C; De Stefano D; Capuozzo A; Irace C; Iuvone T; Santamaria R; Carnuccio R; Lavecchia A
Biochem Pharmacol; 2016 Mar; 104():83-94. PubMed ID: 26776306
[TBL] [Abstract][Full Text] [Related]
7. Direct Rel/NF-κB inhibitors: structural basis for mechanism of action.
Ouk S; Liou ML; Liou HC
Future Med Chem; 2009 Dec; 1(9):1683-707. PubMed ID: 21425986
[TBL] [Abstract][Full Text] [Related]
8. Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells.
Park J; Ahn KS; Bae EK; Kim BS; Kim BK; Lee YY; Yoon SS
Anticancer Drugs; 2008 Sep; 19(8):777-82. PubMed ID: 18690088
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach.
Egan LJ; Toruner M
Ann N Y Acad Sci; 2006 Aug; 1072():114-22. PubMed ID: 17057194
[TBL] [Abstract][Full Text] [Related]
10. Regulation of NF-kB in multiple myeloma: therapeutic implications.
Feinman R; Siegel DS; Berenson J
Clin Adv Hematol Oncol; 2004 Mar; 2(3):162-6. PubMed ID: 16166946
[TBL] [Abstract][Full Text] [Related]
11. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
12. Dynamic protein complexes regulate NF-kappaB signaling.
Wegener E; Krappmann D
Handb Exp Pharmacol; 2008; (186):237-59. PubMed ID: 18491055
[TBL] [Abstract][Full Text] [Related]
13. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
14. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy.
Acharyya S; Villalta SA; Bakkar N; Bupha-Intr T; Janssen PM; Carathers M; Li ZW; Beg AA; Ghosh S; Sahenk Z; Weinstein M; Gardner KL; Rafael-Fortney JA; Karin M; Tidball JG; Baldwin AS; Guttridge DC
J Clin Invest; 2007 Apr; 117(4):889-901. PubMed ID: 17380205
[TBL] [Abstract][Full Text] [Related]
15. Japonicone A suppresses growth of Burkitt lymphoma cells through its effect on NF-κB.
Li X; Yang X; Liu Y; Gong N; Yao W; Chen P; Qin J; Jin H; Li J; Chu R; Shan L; Zhang R; Zhang W; Wang H
Clin Cancer Res; 2013 Jun; 19(11):2917-28. PubMed ID: 23620411
[TBL] [Abstract][Full Text] [Related]
16. The role of NF-kappaB in lymphoid malignancies.
Packham G
Br J Haematol; 2008 Oct; 143(1):3-15. PubMed ID: 18573107
[TBL] [Abstract][Full Text] [Related]
17. Dimeric procyanidin B2 inhibits constitutively active NF-kappaB in Hodgkin's lymphoma cells independently of the presence of IkappaB mutations.
Mackenzie GG; Adamo AM; Decker NP; Oteiza PI
Biochem Pharmacol; 2008 Apr; 75(7):1461-71. PubMed ID: 18275936
[TBL] [Abstract][Full Text] [Related]
18. Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice.
Saadane A; Masters S; DiDonato J; Li J; Berger M
Am J Respir Cell Mol Biol; 2007 Jun; 36(6):728-36. PubMed ID: 17272824
[TBL] [Abstract][Full Text] [Related]
19. Suppression of the NF-kappaB signalling pathway by ergolide, sesquiterpene lactone, in HeLa cells.
Chun JK; Seo DW; Ahn SH; Park JH; You JS; Lee CH; Lee JC; Kim YK; Han JW
J Pharm Pharmacol; 2007 Apr; 59(4):561-6. PubMed ID: 17430640
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression.
Bassères DS; Baldwin AS
Oncogene; 2006 Oct; 25(51):6817-30. PubMed ID: 17072330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
